申请人:ADIR et Compagnie
公开号:US05506245A1
公开(公告)日:1996-04-09
The compounds are 5-(4-substituted benzyl)thiazolidine-2,4-diones, enantiomers, diastereoisomers and pharmaceutically tolerable salts thereof, useful for treating conditions of insulin-resistance and/or non insulin-dependent diabetes. A compound disclosed is: .(R,S)-5-4-[2-benzofuran-2-yl)carbonylamino)ethyl]benzyl}thiazolidine-2,4 -dione.
这些化合物是5-(4-取代苯基)噻唑烷-2,4-二酮,对映体,非对映异构体和药物耐受盐,可用于治疗胰岛素抵抗和/或非胰岛素依赖性糖尿病。其中一种化合物被披露为:(R,S)-5-4-[2-苯并呋喃-2-基)羧酰胺)乙基]苯甲基}噻唑烷-2,4-二酮。